Literature DB >> 1728252

The positive-negative distinction in schizophrenia. Review of natural history validators.

T H McGlashan1, W S Fenton.   

Abstract

A review of the interaction between the positive-negative symptom distinction in schizophrenia and multiple measures of illness natural history reveals some redundant and compelling patterns. Negative or deficit symptoms are often associated with inferior social/instrumental functioning premorbidly, more abnormal voluntary/involuntary movements at illness presentation, and poorer long-term outcome when present beyond the early phase of illness. Negative symptoms are semi-independent of positive symptoms. They are variable early in the illness but accrue in severity, stability, and prognostic weight with time. The nature of the processes that generate negative symptoms and their specificity to schizophrenia remain to be elucidated. Nevertheless, it is clear that negative symptoms are a common and valid component of schizophrenia and deserve recognition as such in our nosology.

Entities:  

Mesh:

Year:  1992        PMID: 1728252     DOI: 10.1001/archpsyc.1992.01820010063008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  36 in total

1.  Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong.

Authors:  Frederick Ka Ching Yeung; Sunny Ho Wan Chan
Journal:  Qual Life Res       Date:  2006-09-07       Impact factor: 4.147

Review 2.  Platelets: A possible glance into brain biological processes in schizophrenia.

Authors:  Eyal Asor; Dorit Ben-Shachar
Journal:  World J Psychiatry       Date:  2012-12-22

3.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia.

Authors:  Karoline Schneider; Lars Michels; Matthias N Hartmann-Riemer; Achim Burrer; Philippe N Tobler; Philipp Stämpfli; Matthias Kirschner; Erich Seifritz; Stefan Kaiser
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

Review 5.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

6.  Positive and negative symptoms in families with schizophrenia.

Authors:  A S Bassett; E J Collins; S E Nuttall; W G Honer
Journal:  Schizophr Res       Date:  1993-12       Impact factor: 4.939

7.  Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.

Authors:  Victor Peralta; Lucía Moreno-Izco; Ana Sanchez-Torres; Elena García de Jalón; Maria S Campos; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2012-12-18       Impact factor: 9.306

8.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

9.  Reemergence of positive symptoms of schizophrenia during the course of treatment with risperidone.

Authors:  P Bajaj; N Nihalani; N Shah; N Desai; V Shinde; N Raut
Journal:  Indian J Psychiatry       Date:  1999-04       Impact factor: 1.759

10.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.